Kinetic Study of Natural Anticancer Drug (Zerumbone) Release from Zeolite Y-Gelatin Hybrid for Oral Controlled Delivery
DOI:
https://doi.org/10.21834/e-bpj.v9iSI17.5441Keywords:
Kinetic Study , Oral Controlled Release , Zeolite Y , ZerumboneAbstract
A hybrid of zeolite Y-gelatin film as an oral dosage form for the natural anticancer drug was achieved by homogenously incorporating the drug-loaded zeolite Y into the gelatin solution. Drug ability was analyzed using computational and experimental approaches, drug encapsulation efficiency via the BET method, and possible interactions by FTIR analyses. Zerumbone released was done in both pH 1.2 and pH 7.4 mimicking the human gastrointestinal tract conditions for 24 hrs and subjected to kinetics study via suitable mathematical models to determine what governs the drug release with the results indicating that a sustained delivery of once-daily oral dosage form could be achieved.
References
Abdul, A.B.H., Al-Zubairi, A.S., Tailan, N.D., Wahab, S.I.A., Zain,Z., Ruslay, N.M., & Syam. S. (2008). Anticancer Activity of Natural Compound (Zerumbone Extracted from Zingiber zerumbet in Human HeLa Cervical Cancer Cells). Int Journal of Pharmacology 4, 160–168. DOI: https://doi.org/10.3923/ijp.2008.160.168
Aljunid,S.M., Zafar,A., Saperi, S. (2010). Burden of disease associated with cervical cancer in Malaysia and potential costs and consequences of HPV vaccination. Asian Pac J Cancer Prev, 11(6), 1551-1559.
Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccines. WHO. World Health Organization (2017).
Chabner, B.A. and Jr. Robert. T.G. (2005). Timeline: Chemotherapy and the war on cancer. Nat.Rev. Cancer, 65-72 DOI: https://doi.org/10.1038/nrc1529
Datt, A. Applications of mesoporous silica and zeolites for drug delivery. University of Iowa (2012).
Migneault, I., Dartiguenave, C., Bertrand, M.J., & Waldron, K.C. (2004). Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking. BioTechniques, 37, 790-802. DOI: https://doi.org/10.2144/04375RV01
Mukarami, A., Daisuke, T., Takashi, K., Koichi, K., Kim, H.W….Hajime, O. (2002). Zerumbone, a southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the αβ-unsaturated carbonyl group is a prerequisite. Carcinogenesis, 23(5), 795-802. DOI: https://doi.org/10.1093/carcin/23.5.795
Nichols, J.W., & Bae, Y.H. (2014). EPR: Evidence and fallacy. Journal of Controlled Release, 190, 451-464. DOI: https://doi.org/10.1016/j.jconrel.2014.03.057
Rahman, H.A., Rasedee, A., Yeap, S.K., Othman, H.H., Chart and M.S. (2014). Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. Bio Med. Res. Int. DOI: https://doi.org/10.1155/2014/920742
Rayan, A., Raiyn, J., and Falah, J. (2017). Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. PLoS ONE, 12(11), 1-14. DOI: https://doi.org/10.1371/journal.pone.0187925
Ribeiro, L., Alcântara, N.M., Ana, C.S., Rodrigues Da Silva., Gustavo, H., … Michelle, F.M. (2017). Advances in Hybrid Polymer-Based Materials for Sustained Drug Release. International Journal of Polymer Science. 16 DOI: https://doi.org/10.1155/2017/1231464
Salazar, H, Lima, A.C., Lopes, A.C., Botelho, G., Lanceros-Mendez, S. (2015). Poly (vinylidene fluoride-trifluoromethyl)/NAY zeolite hybrid membranes as drug release platform applied to ibuprofen release. Colloids Surf a Physicochem Eng Asp, 469, 93-99. DOI: https://doi.org/10.1016/j.colsurfa.2014.12.064
Santoro, M., & Tatara, A.M. (2014). Gelatin carriers for drug and cell delivery in tissue engineering. J Controlled Release, 190. DOI: https://doi.org/10.1016/j.jconrel.2014.04.014
Shanthi, V., Majdah, M., Syed Aljunid et al. (2012). Cervical cancer in Malaysia: can we improve our screening and preventive practice? BMC Public Health. 12(2), 17. DOI: https://doi.org/10.1186/1471-2458-12-S2-A17
Singh, S., Bhupender, S., Kanwar, S.S., Kumar. A. (2016). Lead phytochemicals for anticancer drug development. Front Plant Sci, 7, 1667. DOI: https://doi.org/10.3389/fpls.2016.01667
Weaver, B.A. (2014). How taxol/paclitaxel kills cancer cells. Mol Biol Cell. 25(18), 2677-2681. DOI: https://doi.org/10.1091/mbc.e14-04-0916
Wen, H., & Park, K. (2010). Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice (pp. 245–256) John Wiley & Sons. DOI: https://doi.org/10.1002/9780470640487
Workman. P. (2005). New cancer drugs are on the horizon. Future Oncol, 1(3), 315-318. DOI: https://doi.org/10.1517/14796694.1.3.315
Zaridah, S. (2014). A Review of Cervical Cancer Research in Malaysia, J. Malaysia, 69.
Zhang, Y.C., Leong, H.F., & Kam, W. (2013). Advanced materials and processing for drug delivery: The past and the future. Advanced Drug Delivery Reviews, 65(1), 104-120. DOI: https://doi.org/10.1016/j.addr.2012.10.003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rosmamuhamadani Ramli, Norashikin Salleh, Mohd Muzamir Mahat, Sabrina M Yahaya
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.